Gemtuzumab (Anti-Siglec-3 / CD33)
Gemtuzumab (Anti-Siglec-3 / CD33) (A3161-GRP)
Products
Description
Gemtuzumab (Anti-Siglec-3 / CD33) a monoclonal antibody targeting CD33 antigen, which present on leukemic myeloblasts of acute myeloid leukemia (AML). It can be used for the research of acute myeloid leukemia.MW :145.22 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A3161 |